PRESS RELEASES

Contacts: Anthony Viscogliosi, Small Bone Innovations, Inc. (212) 583-9700 ext. 100
Nick Kilsby, Creative Partners, (203) 750-9212, Cell: 203-829-6400

SMALL BONE INNOVATIONS, INC. TO PRESENT AT THE FIRST ALBANY CAPITAL 2ND ANNUAL ORTHOPEDIC CONFERENCE

Chairman & CEO Anthony Viscogliosi scheduled to discuss the small bone & joint leader and what SBi has in store for 2007

SBi Team in San Diego for the American Academy of Orthopaedic Surgeons 2007 Annual Meeting

NEW YORK NY, February 9, 2007 - Small Bone Innovations, Inc. (SBi), a single-source provider of innovation, products, technology and education for the small bone & joint sector of the orthopedic industry, has announced that its Founder, Chairman & CEO, Anthony G. Viscogliosi, will be presenting at the First Albany Capital 2nd Annual Orthopedic conference on Tuesday, February 13, 2007, at 8:10am Pacific time. Mr. Viscogliosi will be available during a breakout session, immediately following his presentation, at 8:30am. The conference is being held at the Marina Village Conference Center in San Diego, California.

Commenting on the First Albany Conference, Viscogliosi said, “Bill Plavonic and his team at First Albany Capital hosted a superb event last year in Chicago, which I was honored to be a part of, and judging from this year’s line-up of impressive public and private presenting companies, it promises to be another tremendous event.”

Viscogliosi added, “Small Bone Innovations had a record-setting year on many fronts in 2006. I look forward to sharing with the FAC attendees, the great strides we made to serve small bone & joint surgeons and their patients, as well as many of the exciting plans we have for 2007.”

About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC, (VB), the New York-based merchant banking firm that specializes in the musculoskeletal /orthopedic sector. VB created SBi as the first company to focus purely on small bone & joint science. By integrating established companies and professionals in the field, SBi today offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints.

In establishing SBi, VB acquired several prominent US, Canadian and European orthopedic device companies and product technology licenses focused on small bone and joint treatment, including arthroplasty, internal & external fixation, trauma, and biologics.

SBi completed a Series B financing, raising a record total of $42.2 million, announced in January, 2006. Based on data provided by Venture Source, this was the largest venture capital investment ever recorded in the field of orthopedic devices

SBi was a 2006 recipient of Red Herring magazine's annual “'Red Herring 100 North America" award, recognized as one of the nation's leading technology companies and the only orthopedic device company selected among an initial entry of more than one thousand firms. Additionally, SBi's Artelon CMC-I Spacer, developed for patients with thumb base osteoarthritis, was featured on the cover and highlighted within Medical Design Technology magazine's “"Year of Innovation" issue as one of the most fascinating technologies influencing the medical device industry.

For more information on SBi, please visit: www.totalsmallbone.com

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
 
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry.  They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.

For more information about VB, please visit: www.vbllc.com


> Back to Press Releases